Table 5 Stability of gene selection
Dataset | Classifier | The genes selected and their occurrence percentages across the CV loop |
|---|---|---|
Melanoma | SGC-t | 200965_s_at (99%), 213050_at (1%) |
| Â | SGC-W | 217906_at (92%), 218552_at (4%), 218996_at (1%), 219343_at (1%), 221577_x_at (1%), 221882_s_at (1%) |
Breast Cancer 1 | SGC-t | 259466 (92%), 291660 (5%), 950574 (3%) |
| Â | SGC-W | 259466 (98%), 291660 (2%) |
Brain Cancer | SGC-t | J02611_at (95%), X53331_at (5%) |
| Â | SGC-W | J02611_at (93%), X67951_at (3%), HG3543-HT3739_at (2%), X12794_at (2%), |
Breast Cancer 2 | SGC-t | AI868854 (65%), AK026899 (13%), AK026789 (12%), AK025709 (3%), AI240933 (3%), AF119844 (2%), AW006861 (2%) |
| Â | SGC-W | N30081 (65%), AF119844 (23%), AI868854 (12%) |
Gastric Tumor | SGC-t | W70254 (100%) |
| Â | SGC-W | AA171606 (94%), W70254 (6%) |
Lung Cancer 1 | SGC-t | 37210_at (66%), 198_g_at (15%), 40165_at (12%), 32254_at (5%), 41344_s_at (2%) |
| Â | SGC-W | 1252_at (100%) |
Lung Cancer 2 | SGC-t | 33754_at (100%) |
| Â | SGC-W | 40936_at (98%), 33833_at (0.5%), 34320_at (0.5%), 37157_at (0.5%), 39640_at (0.5%) |
Lymphoma | SGC-t | X76538_at (100%) |
| Â | SGC-W | X76538_at (91%), D30655_at (9%) |
Myeloma | SGC-t | 33146_at (88%), 32546_at (12%) |
| Â | SGC-W | 32546_at (99%), 1071_at (1%) |
Pancreatic Cancer | SGC-t | 209596_at (98%), 206451_at (2%) |
| Â | SGC-W | 206451_at (45%), 209596_at (43%), 218498_s_at (6%), 219625_s_at (4%), 212058_at (2%) |
Prostate Cancer | SGC-t | 34452_at (100%) |
| Â | SGC-W | 34452_at (100%) |